Akorn, Inc. has signed a 10-year operating lease for a newly constructed product development facility located in Gurnee, IL. This site, a Center for Excellence, will centralize Akorn’s new product development activities,  consolidating development efforts that are presently managed in Decatur, IL and Somerset, NJ.

Shawn L. Silvestri, Ph.D., vice president, new product development, stated, “This new, state-of-the art facility will position Akorn to compete on a global basis, enabling us to attract and recruit top-tier scientific talent. The facility will conform to the tenets of cGLP (current Good Laboratory Practices) for R&D activities and will fulfill all requirements for the development of Akorn’s pipeline of NDA and ANDA filings for prescription drug products.”